Optimal dosing of cefotaxime and desacetylcefotaxime for critically ill paediatric patients. Can we use microsampling?

Guerra Valero, Yarmarly C; Dorofaeff, Tavey; Coulthard, Mark G; Sparkes, Louise; Lipman, Jeffrey; Wallis, Steven C; Roberts, Jason A; Parker, Suzanne L

Guerra Valero, Yarmarly C; Dorofaeff, Tavey; Coulthard, Mark G; Sparkes, Louise; Lipman, Jeffrey; Wallis, Steven C; Roberts, Jason A; Parker, Suzanne L.

Afiliación

Guerra Valero YC; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Dorofaeff T; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Coulthard MG; Paediatric Intensive Care, Queensland Children's Hospital, Brisbane, Australia.
Sparkes L; Paediatric Intensive Care, Queensland Children's Hospital, Brisbane, Australia.
Lipman J; Mayne Academy of Paediatrics, Faculty of Medicine, The University of Queensland, Brisbane, Australia.
Wallis SC; Paediatric Intensive Care, Queensland Children's Hospital, Brisbane, Australia.
Roberts JA; UQ Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Parker SL; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, Australia.

J Antimicrob Chemother ; 77(8): 2227-2237, 2022 07 28.

Article en En | MEDLINE | ID: mdl-35678266

Asunto(s)

Cefotaxima; Enfermedad Crítica; Antibacterianos/farmacología; Bacterias; Cefotaxima/análogos & derivados; Niño; Humanos; Pruebas de Sensibilidad Microbiana; Método de Montecarlo

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cefotaxima / Enfermedad Crítica Tipo de estudio: Health_economic_evaluation Límite: Child / Humans Idioma: En Revista: J Antimicrob Chemother Año: 2022 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google